Categories Earnings, Other Industries
Pharmacy growth might aid Walgreens to deliver upbeat Q4 results
Walgreens Boots Alliance (WBA) sales from its pharmacy stores are likely on the upward growth for the recently completed fourth-quarter as analysts expect upbeat results for the quarter. The drugstore chain is slated to announce its fourth-quarter financial results on Thursday before the market opens. Ahead of the release, investors are cautious as the stock opened lower on Tuesday and remained grounded.
Analysts, on average, expect the company to earn $1.45 per share compared to $1.31 per share reported in the previous year quarter. Sales are anticipated to increase by 12% to $33.78 billion. Most of the analysts recommended a “strong buy” or “buy” rating on the stock with an average price target of $73.61.
With more than half of Rite Aid (RAD) pharmacies under its hood, Walgreens is securing its position in the healthcare space. This is in the midst of the threat of Amazon (AMZN) entering the pharmacy space that has created immense pressure on other existing players. Walgreens is also facing another pressure from rival CVS Health (CVS) that is due in acquiring Aetna (AET) later this year.
In the third quarter, Walgreens posted a 16% jump in earnings as it brought more patients to its US pharmacies through the recent purchase of Rite Aid stores and through strategic partnership. Sales increased 14% on higher prescription volume from the Rite Aid stores acquisition and from central specialty.
US pharmacy sales grew 19%, and Retail Pharmacy USA increased by 15%. Retail Pharmacy International sales improved 6.6%, and Pharmaceutical Wholesale sales grew 12.6%. The company had lifted the low end of its fiscal year 2018 earnings outlook by five cents.
It is expected that the company will be providing guidance for the fiscal year 2019 and its long-term strategic goals during the earnings call. Walgreens is likely to declare the unchanged $0.44 per share quarterly dividend, and the board is predicted to give more information on the development of the last quarter authorized share repurchase program.
Most Popular
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome. The company has been facing challenges in certain
eBay (EBAY): A few factors that helped drive growth in Q3 2024
Shares of eBay Inc. (NASDAQ: EBAY) stayed green on Friday. The stock has gained 32% year-to-date. The ecommerce leader delivered revenue and earnings growth for the third quarter of 2024,
CVX Earnings: Chevron reports lower revenue and profit for Q3 2024
Energy exploration company Chevron Corporation (NYSE: CVX) on Friday announced third-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation dropped to